Philip C. Bourne

454 total citations
21 papers, 381 citations indexed

About

Philip C. Bourne is a scholar working on Molecular Biology, Ecology and Molecular Medicine. According to data from OpenAlex, Philip C. Bourne has authored 21 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Ecology and 6 papers in Molecular Medicine. Recurrent topics in Philip C. Bourne's work include Bacteriophages and microbial interactions (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Bacillus and Francisella bacterial research (6 papers). Philip C. Bourne is often cited by papers focused on Bacteriophages and microbial interactions (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Bacillus and Francisella bacterial research (6 papers). Philip C. Bourne collaborates with scholars based in United States, United Kingdom and Switzerland. Philip C. Bourne's co-authors include William W. Barrow, Esther W. Barrow, Christina R. Bourne, Michail N. Isupov, Richard A. Bunce, K. Darrell Berlin, Jennifer A. Littlechild, Andrew Dalby, Baskar Nammalwar and Stefan Reinelt and has published in prestigious journals such as Journal of Molecular Biology, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Philip C. Bourne

21 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip C. Bourne United States 11 272 98 97 63 40 21 381
Aaron Korkegian United States 10 383 1.4× 101 1.0× 97 1.0× 98 1.6× 16 0.4× 20 517
Markus Lakemeyer Germany 10 255 0.9× 104 1.1× 60 0.6× 65 1.0× 58 1.4× 16 447
Colin J. Dunsmore United Kingdom 9 322 1.2× 124 1.3× 32 0.3× 87 1.4× 32 0.8× 11 462
Dale F. Kreitler United States 14 395 1.5× 137 1.4× 56 0.6× 47 0.7× 11 0.3× 29 520
Ellene H. Mashalidis United States 10 380 1.4× 94 1.0× 49 0.5× 85 1.3× 70 1.8× 13 531
Kimberly D. Grimes United States 8 224 0.8× 85 0.9× 37 0.4× 48 0.8× 30 0.8× 9 354
Elke Brosens Belgium 10 373 1.4× 49 0.5× 88 0.9× 48 0.8× 14 0.3× 14 507
Valéry Larue France 14 322 1.2× 106 1.1× 30 0.3× 45 0.7× 9 0.2× 30 531
A. Magnusdottir Sweden 8 270 1.0× 38 0.4× 122 1.3× 26 0.4× 18 0.5× 8 492
Steven Pratt United Kingdom 12 244 0.9× 163 1.7× 21 0.2× 50 0.8× 33 0.8× 15 473

Countries citing papers authored by Philip C. Bourne

Since Specialization
Citations

This map shows the geographic impact of Philip C. Bourne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip C. Bourne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip C. Bourne more than expected).

Fields of papers citing papers by Philip C. Bourne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip C. Bourne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip C. Bourne. The network helps show where Philip C. Bourne may publish in the future.

Co-authorship network of co-authors of Philip C. Bourne

This figure shows the co-authorship network connecting the top 25 collaborators of Philip C. Bourne. A scholar is included among the top collaborators of Philip C. Bourne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip C. Bourne. Philip C. Bourne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nurmemmedov, Elmar, et al.. (2020). Evolution of a 4-Benzyloxy-benzylamino Chemotype to Provide Efficacious, Potent, and Isoform Selective PPARα Agonists as Leads for Retinal Disorders. Journal of Medicinal Chemistry. 63(6). 2854–2876. 13 indexed citations
2.
Nammalwar, Baskar, Christina R. Bourne, Philip C. Bourne, et al.. (2014). Synthesis and Biological Evaluation of 2,4-Diaminopyrimidine-Based Antifolate Drugs against Bacillus anthracis. Molecules. 19(3). 3231–3246. 7 indexed citations
3.
Nammalwar, Baskar, Christina R. Bourne, Philip C. Bourne, et al.. (2014). Modified 2,4-diaminopyrimidine-based dihydrofolate reductase inhibitors as potential drug scaffolds against Bacillus anthracis. Bioorganic & Medicinal Chemistry. 23(1). 203–211. 12 indexed citations
4.
Nammalwar, Baskar, Richard A. Bunce, K. Darrell Berlin, et al.. (2013). Comparative Study of the Frech Catalyst with Two Conventional Catalysts in the Heck Synthesis of 2,4-Diaminopyrimidine-based Antibiotics. Organic Preparations and Procedures International. 45(1). 66–71. 3 indexed citations
5.
Nammalwar, Baskar, Richard A. Bunce, K. Darrell Berlin, et al.. (2012). Synthesis and biological activity of substituted 2,4-diaminopyrimidines that inhibit Bacillus anthracis. European Journal of Medicinal Chemistry. 54. 387–396. 24 indexed citations
6.
Bourne, Christina R., Baskar Nammalwar, Philip C. Bourne, et al.. (2012). Structure–activity relationship for enantiomers of potent inhibitors of B. anthracis dihydrofolate reductase. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1834(1). 46–52. 10 indexed citations
7.
Barrow, Esther W., Kimberly D. Hill, Philip C. Bourne, et al.. (2012). High-Throughput Screening of a Diversity Collection Using Biodefense Category A and B Priority Pathogens. SLAS DISCOVERY. 17(7). 946–956. 4 indexed citations
8.
Nammalwar, Baskar, Christina R. Bourne, Richard A. Bunce, et al.. (2012). Inhibition of Bacterial Dihydrofolate Reductase by 6‐Alkyl‐2,4‐diaminopyrimidines. ChemMedChem. 7(11). 1974–1982. 12 indexed citations
9.
Nammalwar, Baskar, Richard A. Bunce, K. Darrell Berlin, et al.. (2012). Microwave-assisted Heck Synthesis of Substituted 2,4-Diaminopyrimidine-based Antibiotics. Organic Preparations and Procedures International. 44(3). 281–287. 5 indexed citations
10.
Bourne, Christina R., Esther W. Barrow, Richard A. Bunce, et al.. (2010). Inhibition of Antibiotic-Resistant Staphylococcus aureus by the Broad-Spectrum Dihydrofolate Reductase Inhibitor RAB1. Antimicrobial Agents and Chemotherapy. 54(9). 3825–3833. 36 indexed citations
11.
Bourne, Christina R., Richard A. Bunce, Philip C. Bourne, et al.. (2009). Crystal Structure of Bacillus anthracis Dihydrofolate Reductase with the Dihydrophthalazine-Based Trimethoprim Derivative RAB1 Provides a Structural Explanation of Potency and Selectivity. Antimicrobial Agents and Chemotherapy. 53(7). 3065–3073. 37 indexed citations
12.
Valderas, Michelle Wright, Philip C. Bourne, & William W. Barrow. (2007). Genetic Basis for Sulfonamide Resistance in Bacillus anthracis. Microbial Drug Resistance. 13(1). 11–20. 10 indexed citations
13.
Barrow, Esther W., Jürg Dreier, Stefan Reinelt, Philip C. Bourne, & William W. Barrow. (2007). In Vitro Efficacy of New Antifolates against Trimethoprim-Resistant Bacillus anthracis. Antimicrobial Agents and Chemotherapy. 51(12). 4447–4452. 30 indexed citations
14.
Bourne, Philip C., et al.. (2004). Three-dimensional structures of a humanized anti-IFN-γ Fab (HuZAF) in two crystal forms. Acta Crystallographica Section D Biological Crystallography. 60(10). 1761–1769. 6 indexed citations
15.
Barrow, Esther W., Philip C. Bourne, & William W. Barrow. (2004). Functional Cloning of Bacillus anthracis Dihydrofolate Reductase and Confirmation of Natural Resistance to Trimethoprim. Antimicrobial Agents and Chemotherapy. 48(12). 4643–4649. 28 indexed citations
16.
Terzyan, S., Christina R. Bourne, Paul A. Ramsland, Philip C. Bourne, & Allen B. Edmundson. (2003). Comparison of the three‐dimensional structures of a human Bence‐Jones dimer crystallized on Earth and aboard US Space Shuttle Mission STS‐95. Journal of Molecular Recognition. 16(2). 83–90. 8 indexed citations
17.
Bourne, Philip C., Paul A. Ramsland, Lin Shan, et al.. (2002). Three-dimensional structure of an immunoglobulin light-chain dimer with amyloidogenic properties. Acta Crystallographica Section D Biological Crystallography. 58(5). 815–823. 35 indexed citations
18.
Bourne, Philip C., Michail N. Isupov, & Jennifer A. Littlechild. (2000). The atomic-resolution structure of a novel bacterial esterase. Structure. 8(2). 143–151. 37 indexed citations
19.
Bourne, Philip C., Michail N. Isupov, & Jennifer A. Littlechild. (1999). Crystallization and preliminary X-ray diffraction studies of a novel bacterial esterase. Acta Crystallographica Section D Biological Crystallography. 55(4). 915–917. 3 indexed citations
20.
Isupov, Michail N., et al.. (1999). Crystal structure of the glyceraldehyde-3-phosphate dehydrogenase from the hyperthermophilic archaeon Sulfolobus solfataricus 1 1Edited by R. Huber. Journal of Molecular Biology. 291(3). 651–660. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026